AOD-9604 3mg Peptides
Built for studies that demand precision, this lyophilized peptide is prepared to support disciplined, repeatable results in the lab.
AOD-9604 3mg Peptides from Peptide Scientific Labs is a research-only, lyophilized peptide vial designed for controlled laboratory workflows. This format provides the AOD-9604 peptide as a stable dry solid to support careful handling, accurate reconstitution, and consistent experimental planning. Each unit includes one sealed vial with a 3mg fill to fit standard research protocols and inventory management.
- Each vial contains 3mg of AOD-9604 (Human Growth Hormone Fragment 176-191), studied for its role in growth hormone fragment research and metabolic pathway signaling in preclinical models.
As a non-edible laboratory material, this peptide is supplied as a lyophilized solid for precise method development. When properly reconstituted according to your lab’s validated protocol, the material is designed to support clear solutions, controlled aliquoting, and consistent use across replicates. The lot-coded vial presentation aids bench organization, documentation, and traceability in academic, biotech, and industrial research environments.
Researchers value a dependable peptide profile, and this vial is configured to help maintain integrity from receipt to analysis. Use appropriate aseptic technique during reconstitution and transfer. Integrate into your workflow for in vitro assays, exploratory method work, or other bench-scale applications as defined by your institution’s procedures. Store, handle, and dispose of the material in alignment with internal laboratory guidelines and applicable regulations.
Peptide Scientific Labs operates with a quality-first mindset: USA-based production oversight, rigorous lot-level testing for identity and purity, and meticulous handling to reduce variables that can compromise data. Each batch is manufactured to exacting specifications, with packaging and labeling designed to support traceability and confident recordkeeping. No shortcuts—just consistent peptides prepared for serious research.
For laboratory research use only. Not for human or veterinary use. Not for household use, ingestion, or injection. Handle only by qualified personnel in appropriate laboratory settings and follow all applicable laws, regulations, and safety protocols.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
This Product Contains
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What is AOD-9604?
AOD-9604 is a modified fragment of human growth hormone, commonly described as the 176-191 region. In research settings it is presented as a peptide of interest in lipid-metabolism studies, with a profile intended to differ from full-length growth hormone. It should be framed as a research compound only.
What is AOD-9604 typically studied for?
AOD-9604 is most often studied in relation to fat metabolism, lipolysis, and body-weight regulation in experimental models. It is usually distinguished from full HGH by the fact that researchers investigate it for metabolic effects without assuming the broader growth-promoting actions of native growth hormone.
What are GH peptides?
GH peptides — short for growth-hormone-related peptides — are a research category that includes two main subgroups. The first is growth-hormone-releasing hormone (GHRH) analogs, such as Sermorelin, Tesamorelin, and CJC-1295, which are studied for their interaction with the GHRH receptor. The second is growth hormone secretagogues, such as Ipamorelin, GHRP-2, GHRP-6, and Hexarelin, which are studied for their interaction with the ghrelin receptor (GHS-R1a).
Both subgroups are investigated in the research context of growth-hormone-axis biology. All GH peptide products from Peptide Scientific Labs are lyophilized research compounds intended solely for in vitro laboratory investigation.
How do GH peptides differ from recombinant growth hormone?
Recombinant human growth hormone is the full 191-amino-acid human GH protein, produced via recombinant DNA technology. It is essentially identical to the endogenous hormone itself. GH peptides, by contrast, are much shorter sequences — typically on the order of a few to a few dozen amino acids — that do not act as GH themselves but rather engage upstream receptors (GHRH-R or GHS-R1a) involved in the GH signaling axis.
This makes the two categories mechanistically distinct. Recombinant GH is a replacement of the hormone itself, while GH peptides are research tools for studying the regulatory machinery that controls endogenous GH release.
What is the difference between GHRH analogs and GH secretagogues?
GHRH analogs are peptides modeled on the natural growth-hormone-releasing hormone sequence. They are studied for their ability to bind the GHRH receptor on the pituitary — the same receptor used by endogenous GHRH. Examples include Sermorelin (a GHRH 1-29 analog), Tesamorelin, and CJC-1295.
GH secretagogues are a structurally different class of peptides that act through the growth hormone secretagogue receptor (GHS-R1a), better known as the ghrelin receptor. Examples include Ipamorelin, GHRP-2, GHRP-6, and Hexarelin. The two classes engage different receptors and are therefore studied as distinct pharmacological families in research on GH signaling.
